STOCK TITAN

NeOnc CEO buys 10,798 shares in open market

CEO Thomas C. Chen bought NTHI shares in open-market IRA transactions and reported sizable direct and indirect holdings with several beneficial ownership disclaimers.

(Neutral)
(Positive)
Form Type
4

Rhea-AI Filing Summary

NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) CEO and director Thomas C. Chen reported open-market purchases of a total of 10,798 shares of common stock on September 11 and 14, 2026, through an IRA at prices of $3.60 and $3.815 per share. The filing also reports updated direct and indirect holdings across family-related entities and trusts, with several positions subject to beneficial ownership disclaimers limited to Chen’s pecuniary interests.

Positive

  • None.

Negative

  • None.
Insider CHEN THOMAS C
Role CEO
Bought 10,798 shs ($40K)
Type Security Shares Price Value
Purchase Common Stock 5,242 $3.815 $20K
Purchase Common Stock 5,556 $3.60 $20K
holding Common Stock F1 -- -- --
holding Common Stock F2 -- -- --
holding Common Stock F3 -- -- --
holding Common Stock F4 -- -- --
holding Common Stock F5 -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 24,503 shares (Indirect, By IRA); Common Stock — 583,531 shares (Direct); Common Stock — 261,242 shares (Indirect, By HCWG LLC); Common Stock — 888,148 shares (Indirect, By NeuCen Biomedical Co. Ltd.); Common Stock — 2,833,961 shares (Indirect, By TR Chen Third Family Limited Partnership.); Common Stock — 93,253 shares (Indirect, By Tien Duan Chen Trust); Common Stock — 948 shares (Indirect, By Defined Benefit Plan)
Footnotes (5)
  1. F1. Includes shares of common stock held by certain members of Reporting Person's immediate family of which Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest, if any, therein.
  2. F2. Such shares represent only Reporting Person's percentage interest in HCWG LLC.
  3. F3. Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
  4. F4. Shares held by T. R. Chen Third Family Limited Partnership, a NV limited partnership, of which Reporting Person and his spouse are the general partners with sole voting and dispositive power. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
  5. F5. Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest, if any, therein.
Shares purchased September 14, 2026 5,242 shares Common stock bought indirectly through IRA at $3.815 per share
Purchase price September 14, 2026 $3.815 per share Open-market or private purchase of 5,242 common shares through IRA
Shares purchased September 11, 2026 5,556 shares Common stock bought indirectly through IRA at $3.60 per share
Purchase price September 11, 2026 $3.60 per share Open-market or private purchase of 5,556 common shares through IRA
Total shares purchased 10,798 shares Aggregate of two IRA purchases on September 11 and 14, 2026
Direct common shares held 583,531 shares Direct holding entry, including certain immediate family shares, with disclaimer
Indirect shares via TR Chen Third Family Limited Partnership 2,833,961 shares Indirect holding with Chen and spouse as general partners with sole voting and dispositive power
Indirect shares via NeuCen Biomedical Co. Ltd. 888,148 shares Indirect holding; NeuCen is owned in part by Chen’s spouse, with beneficial ownership disclaimed except for pecuniary interest
beneficial ownership financial
"Reporting Person disclaims beneficial ownership of such shares, except to the extent"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership except to the extent of his pecuniary interest"
dispositive power financial
"general partners with sole voting and dispositive power"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
Defined Benefit Plan financial
"Shares held indirectly By Defined Benefit Plan"
A defined benefit plan is a retirement program that guarantees workers a specific monthly payment after they retire, with the employer responsible for funding whatever is needed to meet that promise. Investors care because these plans create long-term payment obligations that can affect a company’s cash flow and balance sheet—similar to a homeowner having a fixed mortgage the household must cover regardless of income swings.
IRA financial
"Common Stock purchased indirectly By IRA in open-market or private transaction"
An individual retirement account (IRA) is a savings account designed to help people put aside money for their retirement, often with tax advantages that encourage long-term savings. It matters to investors because it can grow over time, providing financial security later in life, and offers benefits that can reduce current taxes or allow investments to compound more effectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did NTHI CEO Thomas C. Chen report on this Form 4?

He reported two open-market purchases of NEONC TECHNOLOGIES HOLDINGS, INC. common stock through an IRA on September 11 and 14, 2026, along with updated direct and indirect holdings across several family-related entities and trusts.

How many NTHI shares did Thomas C. Chen purchase and at what prices?

Thomas C. Chen purchased a total of 10,798 shares of NTHI common stock: 5,556 shares at $3.60 per share on September 11, 2026, and 5,242 shares at $3.815 per share on September 14, 2026, all held indirectly through an IRA.

Were Thomas C. Chen’s NTHI share purchases made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that these transactions were made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.

What are Thomas C. Chen’s reported direct NTHI holdings after these transactions?

After these transactions, a holding entry shows 583,531 shares of NTHI common stock held directly, including shares held by certain immediate family members. A footnote states Chen disclaims beneficial ownership except to the extent of his pecuniary interest.

What indirect NTHI holdings are reported for Thomas C. Chen through entities and trusts?

Indirect holdings include 261,242 shares via HCWG LLC, 888,148 shares via NeuCen Biomedical Co. Ltd., 2,833,961 shares via T.R. Chen Third Family Limited Partnership, 93,253 shares via Tien Duan Chen Trust, and 948 shares via a Defined Benefit Plan, with several positions subject to beneficial ownership disclaimers.

How does the Form 4 describe Thomas C. Chen’s beneficial ownership of certain NTHI shares?

Multiple footnotes state that Chen disclaims beneficial ownership of shares held by family members, NeuCen Biomedical, and certain trusts and partnerships, except to the extent of his pecuniary interest, and in some cases note his and his spouse’s voting and dispositive power.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CHEN THOMAS C

(Last)(First)(Middle)
23975 SORRENTO PARK
SUITE 205

(Street)
CALABASAS CALIFORNIA 91302

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NEONC TECHNOLOGIES HOLDINGS, INC. [ NTHI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/11/2026P5,556A$3.619,261IBy IRA
Common Stock583,531(1)D
Common Stock261,242(2)IBy HCWG LLC
Common Stock888,148(3)IBy NeuCen Biomedical Co. Ltd.
Common Stock2,833,961(4)IBy TR Chen Third Family Limited Partnership.
Common Stock93,253(5)IBy Tien Duan Chen Trust
Common Stock948IBy Defined Benefit Plan
Common Stock09/14/2026P5,242A$3.81524,503IBy IRA
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Includes shares of common stock held by certain members of Reporting Person's immediate family of which Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest, if any, therein.
2. Such shares represent only Reporting Person's percentage interest in HCWG LLC.
3. Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
4. Shares held by T. R. Chen Third Family Limited Partnership, a NV limited partnership, of which Reporting Person and his spouse are the general partners with sole voting and dispositive power. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
5. Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest, if any, therein.
Remarks:
/S/ THOMAS C CHEN09/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading